The Latin America, Middle East and Africa Specialty Generics Market would witness market growth of 12.6% CAGR during the forecast period (2023-2030).
The market has recently been driven by a number of causes, including an aging population affected by several life-threatening diseases, cost-cutting measures adopted by renowned healthcare providers, demand from growing industries, and others. Chronic diseases are long-lasting conditions that often require no treatment. However, it can occasionally be managed and treated. A few more extended chronic infections raise the risk of developing cancer. Chronic illnesses are brought on by a changing lifestyle, poor food choices, and the inability to maintain an appropriate weight. As these conditions are becoming more prevalent, there is an increasing need for specialty generics to treat complex chronic diseases.
Chronic diseases, sometimes referred to as non-communicable diseases (NCDs), are conditions that develop over an extended period of time as a result of a combination of genetic, environmental, physiological, and behavioral variables. Most deaths from NCDs are caused by cardiovascular illnesses. These diseases are fueled by pressures such as population aging, increased unplanned urbanization, and bad lifestyles. Obesity, elevated blood glucose, rising blood lipids, and raised blood pressure are all symptoms of unhealthy diets and insufficient exercise in humans. The demand is anticipated to expand as chronic diseases become more prevalent.
According to International Trade Association, non-communicable diseases are to blame for 68% of all fatalities in Saudi Arabia. Over 40 percent of adults are obese, and nearly 18 percent of adults have diabetes. Saudi Arabia will keep increasing the amount it spends on diabetes prevention, treatment, and lifestyle diseases. Diabetes, obesity, and cardiovascular illnesses accounted for 25 to 35 percent of all healthcare spending in Saudi Arabia in 2020. The number of visits to primary healthcare facilities per capita would quadruple due to the demand for preventative care screening for managing chronic diseases. Furthermore, Saudi Arabia is responsible for around 60% of the GCC's pharmaceutical product purchases. The best potential in the area is in the fields of diabetes, cardiovascular, antibiotic, and cancer medications. With all these aspects, the market is predicted to witness growth.
The Brazil market dominated the LAMEA Specialty Generics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,696.9 million by 2030. The Argentina market is exhibiting a CAGR of 13.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 12.3% during (2023 - 2030).
Based on Type, the market is segmented into Injectables, Oral Drugs, and Others. Based on Application, the market is segmented into Inflammatory conditions, Multiple sclerosis, Hepatitis C, Oncology, and Others. Based on End Use, the market is segmented into Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Specialty Generics Market is Projected to reach USD 141.5 Billion by 2030, at a CAGR of 9.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Novartis AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Dr. Reddy’s Laboratories Ltd., Mallinckrodt PLC, Bausch Health Companies, Inc., Viatris, Inc. and Apotex, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Injectables
- Oral Drugs
- Others
By Application
- Inflammatory conditions
- Multiple sclerosis
- Hepatitis C
- Oncology
- Others
By End Use
- Specialty Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Teva Pharmaceuticals Industries Ltd.
- Novartis AG
- Hikma Pharmaceuticals PLC
- Sun Pharmaceutical Industries Ltd.
- Fresenius SE & Co. KGaA
- Dr. Reddy’s Laboratories Ltd.
- Mallinckrodt PLC
- Bausch Health Companies, Inc.
- Viatris, Inc.
- Apotex, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Specialty Generics Market, by Type
1.4.2 LAMEA Specialty Generics Market, by Application
1.4.3 LAMEA Specialty Generics Market, by End Use
1.4.4 LAMEA Specialty Generics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, May – 2023, Jan) Leading Players
Chapter 4. LAMEA Specialty Generics Market by Type
4.1 LAMEA Injectables Market by Country
4.2 LAMEA Oral Drugs Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Specialty Generics Market by Application
5.1 LAMEA Inflammatory conditions Market by Country
5.2 LAMEA Multiple sclerosis Market by Country
5.3 LAMEA Hepatitis C Market by Country
5.4 LAMEA Oncology Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Specialty Generics Market by End Use
6.1 LAMEA Specialty Pharmacy Market by Country
6.2 LAMEA Retail Pharmacy Market by Country
6.3 LAMEA Hospital Pharmacy Market by Country
Chapter 7. LAMEA Specialty Generics Market by Country
7.1 Brazil Specialty Generics Market
7.1.1 Brazil Specialty Generics Market by Type
7.1.2 Brazil Specialty Generics Market by Application
7.1.3 Brazil Specialty Generics Market by End Use
7.2 Argentina Specialty Generics Market
7.2.1 Argentina Specialty Generics Market by Type
7.2.2 Argentina Specialty Generics Market by Application
7.2.3 Argentina Specialty Generics Market by End Use
7.3 UAE Specialty Generics Market
7.3.1 UAE Specialty Generics Market by Type
7.3.2 UAE Specialty Generics Market by Application
7.3.3 UAE Specialty Generics Market by End Use
7.4 Saudi Arabia Specialty Generics Market
7.4.1 Saudi Arabia Specialty Generics Market by Type
7.4.2 Saudi Arabia Specialty Generics Market by Application
7.4.3 Saudi Arabia Specialty Generics Market by End Use
7.5 South Africa Specialty Generics Market
7.5.1 South Africa Specialty Generics Market by Type
7.5.2 South Africa Specialty Generics Market by Application
7.5.3 South Africa Specialty Generics Market by End Use
7.6 Nigeria Specialty Generics Market
7.6.1 Nigeria Specialty Generics Market by Type
7.6.2 Nigeria Specialty Generics Market by Application
7.6.3 Nigeria Specialty Generics Market by End Use
7.7 Rest of LAMEA Specialty Generics Market
7.7.1 Rest of LAMEA Specialty Generics Market by Type
7.7.2 Rest of LAMEA Specialty Generics Market by Application
7.7.3 Rest of LAMEA Specialty Generics Market by End Use
Chapter 8. Company Profiles
8.1 Teva Pharmaceutical Industries Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 Hikma Pharmaceuticals PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Sun Pharmaceutical Industries Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.5 Fresenius SE & Co. KGaA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.6 Dr. Reddy’s Laboratories Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Mallinckrodt PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Viatris, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Apotex, Inc.
8.10.1 Company Overview
TABLE 1 LAMEA Specialty Generics Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Specialty Generics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Specialty Generics Market
TABLE 4 Product Launches And Product Expansions– Specialty Generics Market
TABLE 5 Acquisition and Mergers– Specialty Generics Market
TABLE 6 Approvals and Trials– Specialty Generics Market
TABLE 7 LAMEA Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 8 LAMEA Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 9 LAMEA Injectables Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Injectables Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Oral Drugs Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Oral Drugs Market by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 16 LAMEA Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 17 LAMEA Inflammatory conditions Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Inflammatory conditions Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Multiple sclerosis Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Multiple sclerosis Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Hepatitis C Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Hepatitis C Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Oncology Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Oncology Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 28 LAMEA Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 29 LAMEA Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 33 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 34 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 35 LAMEA Specialty Generics Market by Country, 2019 - 2022, USD Million
TABLE 36 LAMEA Specialty Generics Market by Country, 2023 - 2030, USD Million
TABLE 37 Brazil Specialty Generics Market, 2019 - 2022, USD Million
TABLE 38 Brazil Specialty Generics Market, 2023 - 2030, USD Million
TABLE 39 Brazil Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 40 Brazil Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 41 Brazil Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 42 Brazil Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 43 Brazil Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 44 Brazil Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 45 Argentina Specialty Generics Market, 2019 - 2022, USD Million
TABLE 46 Argentina Specialty Generics Market, 2023 - 2030, USD Million
TABLE 47 Argentina Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 48 Argentina Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 49 Argentina Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 50 Argentina Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 51 Argentina Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 52 Argentina Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 53 UAE Specialty Generics Market, 2019 - 2022, USD Million
TABLE 54 UAE Specialty Generics Market, 2023 - 2030, USD Million
TABLE 55 UAE Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 56 UAE Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 57 UAE Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 58 UAE Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 59 UAE Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 60 UAE Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 61 Saudi Arabia Specialty Generics Market, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia Specialty Generics Market, 2023 - 2030, USD Million
TABLE 63 Saudi Arabia Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 65 Saudi Arabia Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 66 Saudi Arabia Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 67 Saudi Arabia Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 68 Saudi Arabia Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 69 South Africa Specialty Generics Market, 2019 - 2022, USD Million
TABLE 70 South Africa Specialty Generics Market, 2023 - 2030, USD Million
TABLE 71 South Africa Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 72 South Africa Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 73 South Africa Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 74 South Africa Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 75 South Africa Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 76 South Africa Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 77 Nigeria Specialty Generics Market, 2019 - 2022, USD Million
TABLE 78 Nigeria Specialty Generics Market, 2023 - 2030, USD Million
TABLE 79 Nigeria Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 80 Nigeria Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 81 Nigeria Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 82 Nigeria Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 83 Nigeria Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 84 Nigeria Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 85 Rest of LAMEA Specialty Generics Market, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA Specialty Generics Market, 2023 - 2030, USD Million
TABLE 87 Rest of LAMEA Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 88 Rest of LAMEA Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 89 Rest of LAMEA Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 90 Rest of LAMEA Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 91 Rest of LAMEA Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 92 Rest of LAMEA Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 93 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 94 Key Information – Novartis AG
TABLE 95 Key Information – Hikma Pharmaceuticals PLC
TABLE 96 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 97 key information – Fresenius SE & Co. KGaA
TABLE 98 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 99 Key information – Mallinckrodt PLC
TABLE 100 key information – Bausch Health Companies, Inc.
TABLE 101 key information – Viatris, Inc.
TABLE 102 Key Information – Apotex, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2020, May – 2023, Jan) Leading Players
FIG 5 LAMEA Specialty Generics Market share by Type, 2022
FIG 6 LAMEA Specialty Generics Market share by Type, 2030
FIG 7 LAMEA Specialty Generics Market by Type, 2019 - 2030, USD Million
FIG 8 LAMEA Specialty Generics Market share by Application, 2022
FIG 9 LAMEA Specialty Generics Market share by Application, 2030
FIG 10 LAMEA Specialty Generics Market by Application, 2019 - 2030, USD Million
FIG 11 LAMEA Specialty Generics Market share by End Use, 2022
FIG 12 LAMEA Specialty Generics Market share by End Use, 2030
FIG 13 LAMEA Specialty Generics Market by End Use, 2019 - 2030, USD Million
FIG 14 LAMEA Specialty Generics Market share by Country, 2022
FIG 15 LAMEA Specialty Generics Market share by Country, 2030
FIG 16 LAMEA Specialty Generics Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 18 Recent strategies and developments: Novartis AG
FIG 19 Recent strategies and developments: Hikma Pharmaceuticals PLC
FIG 20 Recent strategies and developments: Sun Pharmaceutical Industries Ltd.